fig1
Figure 1. Mechanistic insights into the application of engineered bacterial-based in vivo drug delivery systems for disease therapy. (A) Intestinal in situ production of anti-inflammatory mediators; (B) Diabetes therapy in animal models; (C) Antitumor strategy; (D) Neurodegenerative disease intervention.
